Molecular oncology imaging can improve outcomes, cut waste

Experts from the University of Pennsylvania advocated for the use of advanced molecular imaging in cancer care, citing its value when used from diagnosis to treatment in the Journal of the American Medical Association Oncology.

The PET Center at the Perelman School of Medicine has used PET imaging to detect the spread and size of tumors, determining which patients were most likely to benefit from targeted therapy. Other uses include limiting ineffective treatments by predicting patient response.

“In that case, molecular imaging could have directed treatment to patients highly likely to benefit and spared many other patients the toxic effects and costs of ineffective therapy,” Mankoff said.

Follow the link below to read the news release at PennMedicine.org.

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.